Insider & Cluster Buy Highlights – January 28, 2026
📅 Published: January 28, 2026 at 01:22 PM UTC
1 Cluster Buys5 Insider Purchases
On January 28, 2026, this newsletter featured 1 cluster buy and 5 insider purchases detected from SEC Form 4 filings.
📈 Daily Insider & Cluster Buy Highlights – January 28, 2026
Here are some of the most interesting insider and cluster buying signals from the last 7 days.
⚠️ For information purposes only.
This information is provided for informational purposes only and does not constitute investment advice, financial advice, trading advice, or any other type of advice. All investments carry risk, including the potential loss of principal. Past performance is not indicative of future results. You should consult with a qualified financial advisor, accountant, or other professional before making any investment decisions. The information contained in this newsletter is not intended to be a substitute for professional financial advice.
📊 About Fair Value:
The Fair Value shown for each company is calculated using a Levered Discounted Cash Flow (DCF) model. This method estimates the intrinsic value of a stock by projecting future cash flows and discounting them back to present value, accounting for the company's debt structure. A positive percentage difference indicates the stock may be undervalued relative to this model, while a negative percentage suggests it may be overvalued. Fair value calculations are estimates and should be considered alongside other factors.
🔥 Notable Cluster Buys (≥ $500,000)
Streamex CorpView ChartFinancials
Ticker: BSGM
$6.10
Current Price
52W: Low: $0.23 | High: $14.11
Participants: 3 insiders
Total Shares: 1,121,011
Total Value: $3,377,397
Timeframe: 4 days
Date Range: Jan 23, 2026 to Jan 27, 2026
👥 Participant Details:
Lekstrom Morgan Lee
Director
Date: Jan 23, 2026
41,000 shares
$128,486
@ $3.13/share
P&L: +94.7% (+$121,614)
Williams Mitchell Young
Officer
Date: Jan 23, 2026
51,511 shares
$155,852
@ $3.03/share
P&L: +101.6% (+$158,365)
GIUSTRA FRANK
10% Owner
Date: Jan 23, 2026
1,000,000 shares
$3,000,000
@ $3.00/share
P&L: +103.3% (+$3,100,000)
Lekstrom Morgan Lee
Director
Date: Jan 26, 2026
23,000 shares
$75,900
@ $3.30/share
P&L: +84.8% (+$64,400)
Lekstrom Morgan Lee
Director
Date: Jan 27, 2026
5,500 shares
$17,160
@ $3.12/share
P&L: +95.5% (+$16,390)
📈 Average P&L: +96.0% (+692,154)
Current Price: $6.10
📊 Valuation & Analyst Info:
Avg Price Target: $0.41 (-93.3% vs current)
💼 Notable Individual Insider Buys (≥ $100,000)
$2.87
Current Price
Transaction Date: Jan 27, 2026
Shares: 18,018,018
Purchase Price: $2.22
Purchase Value: $40,000,000
📈
P&L: 29.3% ($11,711,712 gain)
📊 Valuation & Analyst Info:
Analyst Rating: D+
📰 Recent News (Last 7 Days):
PRNewsWire • Jan 27, 2026
VANCOUVER, BC, Jan. 27, 2026 /PRNewswire/ - International Tower Hill Mines Ltd. (the "Company") - (TSX: ITH) (NYSE American: THM) today announced that it has closed its previously announced upsized pu...
PRNewsWire • Jan 22, 2026
VANCOUVER, BC, Jan. 22, 2026 /PRNewswire/ - International Tower Hill Mines Ltd. (the "Company") - (TSX: ITH) (NYSE American: THM) today announced the pricing and upsizing of its previously announced p...
PRNewsWire • Jan 22, 2026
VANCOUVER, BC, Jan. 22, 2026 /PRNewswire/ - International Tower Hill Mines Ltd. (the "Company") - (TSX: ITH) (NYSE American: THM) today announced the launch of a $60 million public offering of common ...
$99.27
Current Price
Transaction Date: Jan 23, 2026
Shares: 131,425
Purchase Price: $68.48
Purchase Value: $8,999,984
📈
P&L: 45.0% ($4,046,576 gain)
📊 Valuation & Analyst Info:
Analyst Rating: C-
Avg Price Target: $104.00 (+4.8% vs current)
📰 Recent News (Last 7 Days):
GuruFocus • Jan 27, 2026
Guru Stock PicksChuck Royce has made the following transactions:Reduce in HIFS by 5.13%Add in DSP by 72.29%New position in ANDGStock News Social media addiction
The Motley Fool • Jan 27, 2026
Mirum Pharmaceuticals is at an inflection point. The company's sales are growing fast, led by the success of Livmarli.
Business Wire • Jan 26, 2026
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Completes Acquisition of Bluejay Therapeutics, Expanding Global Leadership in Rare Disease.
Defense World • Jan 26, 2026
Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM - Get Free Report) SVP Jolanda Howe sold 926 shares of the company's stock in a transaction dated Thursday, January 22nd. The stock was sold at an average pri...
Defense World • Jan 26, 2026
Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM - Get Free Report) CFO Eric Bjerkholt sold 1,421 shares of Mirum Pharmaceuticals stock in a transaction on Thursday, January 22nd. The shares were sold at an ...
Defense World • Jan 22, 2026
Emerald Advisers LLC increased its stake in shares of Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) by 20.9% during the undefined quarter, according to its most recent filing with the Securities and Exch...
$11.08
Current Price
Transaction Date: Jan 23, 2026
Shares: 80,000
Purchase Price: $11.81
Purchase Value: $944,672
📉
P&L: 6.2% ($58,272 loss)
📊 Valuation & Analyst Info:
Analyst Rating: C
Avg Price Target: $20.00 (+80.5% vs current)
📰 Recent News (Last 7 Days):
Defense World • Jan 28, 2026
Biodesix, Inc. (NASDAQ: BDSX - Get Free Report) saw a significant growth in short interest in January. As of January 15th, there was short interest totaling 483,591 shares, a growth of 499.1% from the...
$41.03
Current Price
Transaction Date: Jan 23, 2026
Shares: 16,000
Purchase Price: $40.70
Purchase Value: $651,200
📈
P&L: 0.8% ($5,280 gain)
📊 Valuation & Analyst Info:
Analyst Rating: A-
$43.93
Current Price
Transaction Date: Jan 26, 2026
Shares: 5,882
Purchase Price: $42.50
Purchase Value: $249,985
📈
P&L: 3.4% ($8,411 gain)
📊 Valuation & Analyst Info:
Analyst Rating: C
Avg Price Target: $49.95 (+13.7% vs current)
📰 Recent News (Last 7 Days):
Barrons • Jan 28, 2026
Chip makers' shares rally after a solid batch of earnings report signal that the AI boom is still driving up demand for semiconductors.
Market Watch • Jan 28, 2026
CFO David Zinsner recently scooped up $250,000 worth of stock, reflecting “belief in Intel and commitment to creating shareholder value.”
The Motley Fool • Jan 28, 2026
Intel's comeback was interrupted by disappointing Q4 results. Meanwhile, AMD continues to gain market share on multiple fronts.
Defense World • Jan 28, 2026
Intel Corporation (NASDAQ: INTC - Get Free Report)'s stock price rose 3.4% on Tuesday following insider buying activity. The stock traded as high as $44.53 and last traded at $43.93. Approximately 115...
CNBC • Jan 27, 2026
Intel, which now counts the U.S. government as its largest shareholder, said it will match the Trump administration's $1,000 payout for children of eligible U.S. employees. The program, which is a ben...
The Motley Fool • Jan 27, 2026
Intel recently reminded investors that it's struggling to remain competitive. At the same time, the next generation of AI processors is going to be far more purpose-specific than the generalized solut...
Seeking Alpha • Jan 27, 2026
Intel Corporation remains rated Hold, as recent DCAI margin improvements are offset by ongoing supply constraints and uncertain Foundry prospects. INTC's Q1 guidance disappointed, with revenue midpoin...
Fool - Investing News • Jan 27, 2026
There are key questions that have yet to be answered for its valuation.
MarketBeat • Jan 27, 2026
Investors detest uncertainty, and the stock market has a habit of punishing it with extreme prejudice. In the days following its fourth-quarter earnings report, Intel NASDAQ: INTC stock experienced a ...
247 Wallst • Jan 27, 2026
People use many different words to describe Mad Money host Jim Cramer. Could he be characterized as a contrarian, though? The answer is yes as Cramer just made a surprisingly bullish call on shares of...
Investopedia • Jan 27, 2026
Major stock indexes were mixed Tuesday on a busy day of earnings, with the S&P 500 rising to a record high but the Dow Jones Industrial Average falling as shares of UnitedHealth plummeted.
Forbes • Jan 27, 2026
Intel (INTC) stock has declined by 21.8% in under a month, dropping from $54.32 on January 22, 2026, to $42.49 currently, due to a weaker than expected outlook for Q1 FY'26 and concerns about its foun...
Fool - Investing News • Jan 27, 2026
Panther Lake is the company's best PC CPU in years.
Seeking Alpha • Jan 27, 2026
Intel Corporation is at a major inflection point, driven by its advanced 18A manufacturing and Core Ultra Series 3 processors targeting the AI PC market. INTC's Core Ultra Series, powering over 200 PC...
Seeking Alpha • Jan 27, 2026
Intel (INTC) reportedly headline beats for the top and bottom lines in Q4 2025, representing its sixth straight revenue beat. INTC's balance sheet has significantly improved thanks to high profile equ...
Investor Place • Jan 27, 2026
The government is taking equity stakes in American companies. Here are the next Genesis Mission stocks to buy before the capital hits.
The Motley Fool • Jan 26, 2026
Intel's Q4 report beat current targets, but its forward guidance came in well below expectations. Intel warned it lacks manufacturing capacity to meet current demand despite operating near full capaci...
Seeking Alpha • Jan 26, 2026
After its 17% pullback, Intel Corporation stock remains a Hold, as the stock is still up 130% from its August 2025 low and has already priced in a lot of growth optimism. The INTC Q1 FY2026 outlook mi...
Investopedia • Jan 26, 2026
Major stock indexes jumped Monday to begin a busy week of tech earnings and the Federal Reserve's decision on interest rates, while gold futures surpassed $5,000 an ounce for the first time.
GuruFocus • Jan 26, 2026
Intel (INTC) shares slid about 5% in Monday trading, extending losses after its latest earnings report, even as some analysts turned more constructive on a reco
📊 Recent Earnings: Jan 22, 2026
EPS: $0.15 (est: $0.08)
Revenue: $13,674,000,000M (est: $13,433,309,492M)
🏛️ Senate Trading Activity (Past 2 Months):
Gary Peters (MI) - Sale
Date: Dec 12, 2025 | Amount: $15,001 - $50,000 | Owner: Spouse
Gary Peters (MI) - Sale (Full)
Date: Dec 12, 2025 | Amount: $15,001 - $50,000 | Owner: Spouse
This newsletter is generated automatically. Please verify all information independently before making investment decisions.
Want to receive these newsletters in your inbox? Sign up here